“Is There Still a Role for Proactive Therapeutic Drug Monitoring (TDM) in Inflammatory Bowel Disease (IBD): A Review of the Literature” (2025) Canadian IBD Today, 3(1), pp. 36–43. doi:10.58931/cibdt.2025.3142.